Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clinical Trial, Phase 1”

5,398 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,398 results

Early research (Phase 1)Study completedNCT01747213
What this trial is testing

Bisnorcymserine in Healthy Adult Volunteers

Who this might be right for
Healthy Volunteers
National Institute on Aging (NIA) 75
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06680596
What this trial is testing

Detecting Tumor DNA in the Blood of HR+/HER2-low Metastatic Breast Cancer Patients to Find Candidates for T-DXd Therapy

Who this might be right for
Breast Cancer MetastaticBreast Cancer Stage IV
UNICANCER 80
Testing effectiveness (Phase 2)Study completedNCT00040846
What this trial is testing

Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+97 more
Fred Hutchinson Cancer Center 60
Testing effectiveness (Phase 2)UnknownNCT00655460
What this trial is testing

Improving Blood Glucose Control With a Computerized Decision Support Tool: Phase 1

Who this might be right for
Critically IllHyperglycemia
Intermountain Health Care, Inc. 200
Early research (Phase 1)Study completedNCT00327288
What this trial is testing

Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients

Who this might be right for
Non-small Cell Lung CancerBreast CancerProstate Cancer
AmpliMed Corporation 34
Early research (Phase 1)Study completedNCT05273320
What this trial is testing

Clinical Trial of Nabilone for Aggression in Adults With Intellectual and Developmental Disabilities

Who this might be right for
Intellectual DisabilityDevelopmental DisabilityAggression+1 more
Hsiang-Yuan Lin 20
Early research (Phase 1)Looking for participantsNCT06088888
What this trial is testing

TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia

Who this might be right for
Chronic Myelogenous Leukemia
Shenzhen TargetRx Co., Ltd. 90
Early research (Phase 1)Study completedNCT04749641
What this trial is testing

Neoantigen Vaccine Therapy Against H3.3-K27M Diffuse Intrinsic Pontine Glioma

Who this might be right for
Diffuse Intrinsic Pontine Glioma
Yang Zhang 16
Testing effectiveness (Phase 2)UnknownNCT03230708
What this trial is testing

Clinical Study of Autologous Erythrocytes Derived MPs Packaging MTX Peritoneal Perfusion to Treat Malignant Ascites

Who this might be right for
Malignant Ascites
Hui ting Xu，MD 18
Early research (Phase 1)Study completedNCT00821340
What this trial is testing

Clinical Trial of Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations

Who this might be right for
Leber Congenital Amaurosis
Hadassah Medical Organization 3
Testing effectiveness (Phase 2)Looking for participantsNCT06630260
What this trial is testing

5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours

Who this might be right for
Glioblastoma Multiforme (GBM)Glioblastoma Multiform (Grade IV Astrocytoma)Diffuse Hemispheric Glioma, H3 G34-Mutant+1 more
Institute of Cancer Research, United Kingdom 182
Testing effectiveness (Phase 2)Study completedNCT01605513
What this trial is testing

Safety Study of Recombinant Interferon Variant(PEG-IFN-SA) to Treat HCV Disease

Who this might be right for
Hepatitis C Virus
The First Hospital of Jilin University 80
Testing effectiveness (Phase 2)Ended earlyNCT00333424
What this trial is testing

Thai Prophylactic HIV Vaccine Phase I Study

Who this might be right for
HIV
Kirby Institute 8
Early research (Phase 1)Study completedNCT05453786
What this trial is testing

A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers

Who this might be right for
Healthy Subjects
SK Chemicals Co., Ltd. 51
Early research (Phase 1)Study completedNCT04809103
What this trial is testing

Intratumoral Cisplatin for Resectable NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
University of Vermont 6
Large-scale testing (Phase 3)Study completedNCT00002670
What this trial is testing

Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer That Has Been Removed During Surgery

Who this might be right for
Head and Neck Cancer
Radiation Therapy Oncology Group 459
Early research (Phase 1)Ended earlyNCT04751383
What this trial is testing

Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma

Who this might be right for
High Risk NeuroblastomaRecurrent NeuroblastomaRecurrent Osteosarcoma+2 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)WithdrawnNCT03794973
What this trial is testing

Diabetes Autoimmunity Withdrawn in New Onset Patients (DAWN)

Who this might be right for
Diabetes Mellitus, Type 1
Tolerion, Inc.
Early research (Phase 1)Study completedNCT01413113
What this trial is testing

Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery

Who this might be right for
Recurrent Thyroid CancerStage IVA Follicular Thyroid CancerStage IVA Papillary Thyroid Cancer+4 more
University of Washington 6
Testing effectiveness (Phase 2)Study completedNCT01634113
What this trial is testing

Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma

Who this might be right for
Asthma
Boehringer Ingelheim 102
Next Page